FEMSelect
Latest round
- Series B
Last raised
- May 2025
Total raised
- $12M
Investors
- 12
About FEMSelect
Founded in 2012 and based in Israel by Menahem Neuman, FEMSelect Ltd. is a developer of a pelvic floor ligament attachment method to prevent the sagging or falling of the female pelvic organs. As of 2022, Debbie Garner and Renee Selman are the co-CEOs of the company. In October 2022, FEMSelect Ltd. The company also has an office in the US. The company offers EnPlace®, a delivery technology that allows for precise guidance, insertion, and deployment of the anchor unit. EnPlace® is a minimally invasive surgical system that does not require any deep dissection or mesh and is made up of a Nitinol-based anchor, surgical sutures, and a unique attaching mechanism.
Who invested in FEMSelect
12 investors across 3 rounds
See all investors in FEMSelect
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about FEMSelect
Who invested in FEMSelect?
FEMSelect has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has FEMSelect raised?
FEMSelect has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did FEMSelect last raise money?
FEMSelect's most recent round on record is a Series B, in May 2025.
What does FEMSelect do?
Founded in 2012 and based in Israel by Menahem Neuman, FEMSelect Ltd.
Where is FEMSelect headquartered?
FEMSelect is headquartered in Israel.
Which VCs invest in companies like FEMSelect?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at FEMSelect's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like FEMSelect? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.